ID PUR2_BOVIN Reviewed; 1010 AA. AC Q59A32; DT 03-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 26-APR-2005, sequence version 1. DT 24-JAN-2024, entry version 124. DE RecName: Full=Trifunctional purine biosynthetic protein adenosine-3 {ECO:0000250|UniProtKB:P22102}; DE Includes: DE RecName: Full=Phosphoribosylamine--glycine ligase {ECO:0000250|UniProtKB:P22102}; DE EC=6.3.4.13 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=Glycinamide ribonucleotide synthetase; DE Short=GARS; DE AltName: Full=Phosphoribosylglycinamide synthetase; DE Includes: DE RecName: Full=Phosphoribosylformylglycinamidine cyclo-ligase {ECO:0000250|UniProtKB:P22102}; DE EC=6.3.3.1 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=AIR synthase; DE Short=AIRS; DE AltName: Full=Phosphoribosyl-aminoimidazole synthetase; DE Includes: DE RecName: Full=Phosphoribosylglycinamide formyltransferase {ECO:0000250|UniProtKB:P22102}; DE EC=2.1.2.2 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=5'-phosphoribosylglycinamide transformylase; DE AltName: Full=GAR transformylase; DE Short=GART; GN Name=GART; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLU-771. RX PubMed=15777723; DOI=10.1016/j.gene.2004.12.038; RA Woehlke A., Droegemueller C., Kuiper H., Leeb T., Distl O.; RT "Molecular characterization and chromosomal assignment of the bovine RT glycinamide ribonucleotide formyltransferase (GART) gene on cattle RT chromosome 1q12.1-q12.2."; RL Gene 348:73-81(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Uterus; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Trifunctional enzyme that catalyzes three distinct reactions CC as part of the 'de novo' inosine monophosphate biosynthetic pathway. CC {ECO:0000250|UniProtKB:P22102}. CC -!- CATALYTIC ACTIVITY: CC Reaction=5-phospho-beta-D-ribosylamine + ATP + glycine = ADP + H(+) + CC N(1)-(5-phospho-beta-D-ribosyl)glycinamide + phosphate; CC Xref=Rhea:RHEA:17453, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:57305, ChEBI:CHEBI:58681, CC ChEBI:CHEBI:143788, ChEBI:CHEBI:456216; EC=6.3.4.13; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17454; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-formamido-N(1)-(5-O-phospho-beta-D-ribosyl)acetamidine + ATP CC = 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole + ADP + H(+) + CC phosphate; Xref=Rhea:RHEA:23032, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:137981, CC ChEBI:CHEBI:147287, ChEBI:CHEBI:456216; EC=6.3.3.1; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23033; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(6R)-10-formyltetrahydrofolate + N(1)-(5-phospho-beta-D- CC ribosyl)glycinamide = (6S)-5,6,7,8-tetrahydrofolate + H(+) + N(2)- CC formyl-N(1)-(5-phospho-beta-D-ribosyl)glycinamide; CC Xref=Rhea:RHEA:15053, ChEBI:CHEBI:15378, ChEBI:CHEBI:57453, CC ChEBI:CHEBI:143788, ChEBI:CHEBI:147286, ChEBI:CHEBI:195366; CC EC=2.1.2.2; Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15054; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P15640, ECO:0000255|PROSITE- CC ProRule:PRU00409}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00409}; CC Note=Binds 1 magnesium or manganese ion per subunit. CC {ECO:0000255|PROSITE-ProRule:PRU00409}; CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5- CC amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5- CC phospho-D-ribosyl)glycinamide: step 2/2. CC {ECO:0000250|UniProtKB:P22102}. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; N(1)- CC (5-phospho-D-ribosyl)glycinamide from 5-phospho-alpha-D-ribose 1- CC diphosphate: step 2/2. {ECO:0000250|UniProtKB:P22102}. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; N(2)- CC formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-phospho-D- CC ribosyl)glycinamide (10-formyl THF route): step 1/1. CC {ECO:0000250|UniProtKB:P22102}. CC -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P22102}. CC -!- DOMAIN: The N-terminal ATP-grasp domain carries the CC phosphoribosylamine--glycine ligase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- DOMAIN: The central AIRS domain carries the CC phosphoribosylformylglycinamidine cyclo-ligase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- DOMAIN: The C-terminal GART domain carries the CC phosphoribosylglycinamide formyltransferase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- SIMILARITY: In the N-terminal section; belongs to the GARS family. CC {ECO:0000305}. CC -!- SIMILARITY: In the central section; belongs to the AIR synthase family. CC {ECO:0000305}. CC -!- SIMILARITY: In the C-terminal section; belongs to the GART family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ780930; CAG47113.1; -; Genomic_DNA. DR EMBL; BC122573; AAI22574.1; -; mRNA. DR RefSeq; NP_001035563.1; NM_001040473.2. DR AlphaFoldDB; Q59A32; -. DR SMR; Q59A32; -. DR STRING; 9913.ENSBTAP00000012108; -. DR PaxDb; 9913-ENSBTAP00000012108; -. DR PeptideAtlas; Q59A32; -. DR Ensembl; ENSBTAT00000012108.4; ENSBTAP00000012108.3; ENSBTAG00000009188.5. DR GeneID; 281183; -. DR KEGG; bta:281183; -. DR CTD; 2618; -. DR VEuPathDB; HostDB:ENSBTAG00000009188; -. DR VGNC; VGNC:29255; GART. DR eggNOG; KOG0237; Eukaryota. DR eggNOG; KOG3076; Eukaryota. DR GeneTree; ENSGT00390000000292; -. DR HOGENOM; CLU_005361_0_2_1; -. DR InParanoid; Q59A32; -. DR OMA; EVMQACC; -. DR OrthoDB; 729at2759; -. DR TreeFam; TF106368; -. DR Reactome; R-BTA-73817; Purine ribonucleoside monophosphate biosynthesis. DR UniPathway; UPA00074; UER00125. DR UniPathway; UPA00074; UER00126. DR UniPathway; UPA00074; UER00129. DR Proteomes; UP000009136; Chromosome 1. DR Bgee; ENSBTAG00000009188; Expressed in conceptus and 107 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004637; F:phosphoribosylamine-glycine ligase activity; IBA:GO_Central. DR GO; GO:0004641; F:phosphoribosylformylglycinamidine cyclo-ligase activity; IBA:GO_Central. DR GO; GO:0004644; F:phosphoribosylglycinamide formyltransferase activity; IEA:UniProtKB-EC. DR GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0046084; P:adenine biosynthetic process; IBA:GO_Central. DR GO; GO:0006164; P:purine nucleotide biosynthetic process; IBA:GO_Central. DR CDD; cd08645; FMT_core_GART; 1. DR CDD; cd02196; PurM; 1. DR Gene3D; 3.40.50.20; -; 1. DR Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1. DR Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1. DR Gene3D; 3.40.50.170; Formyl transferase, N-terminal domain; 1. DR Gene3D; 3.90.600.10; Phosphoribosylglycinamide synthetase, C-terminal domain; 1. DR Gene3D; 3.90.650.10; PurM-like C-terminal domain; 1. DR Gene3D; 3.30.1330.10; PurM-like, N-terminal domain; 1. DR HAMAP; MF_00741; AIRS; 1. DR HAMAP; MF_00138; GARS; 1. DR HAMAP; MF_01930; PurN; 1. DR InterPro; IPR011761; ATP-grasp. DR InterPro; IPR013815; ATP_grasp_subdomain_1. DR InterPro; IPR002376; Formyl_transf_N. DR InterPro; IPR036477; Formyl_transf_N_sf. DR InterPro; IPR004607; GART. DR InterPro; IPR001555; GART_AS. DR InterPro; IPR016185; PreATP-grasp_dom_sf. DR InterPro; IPR020561; PRibGlycinamid_synth_ATP-grasp. DR InterPro; IPR000115; PRibGlycinamide_synth. DR InterPro; IPR020560; PRibGlycinamide_synth_C-dom. DR InterPro; IPR037123; PRibGlycinamide_synth_C_sf. DR InterPro; IPR020559; PRibGlycinamide_synth_CS. DR InterPro; IPR020562; PRibGlycinamide_synth_N. DR InterPro; IPR010918; PurM-like_C_dom. DR InterPro; IPR036676; PurM-like_C_sf. DR InterPro; IPR016188; PurM-like_N. DR InterPro; IPR036921; PurM-like_N_sf. DR InterPro; IPR004733; PurM_cligase. DR InterPro; IPR011054; Rudment_hybrid_motif. DR NCBIfam; TIGR00877; purD; 1. DR NCBIfam; TIGR00878; purM; 1. DR NCBIfam; TIGR00639; PurN; 1. DR PANTHER; PTHR10520:SF12; TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3; 1. DR PANTHER; PTHR10520; TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3-RELATED; 1. DR Pfam; PF00586; AIRS; 1. DR Pfam; PF02769; AIRS_C; 1. DR Pfam; PF00551; Formyl_trans_N; 1. DR Pfam; PF01071; GARS_A; 1. DR Pfam; PF02843; GARS_C; 1. DR Pfam; PF02844; GARS_N; 1. DR SMART; SM01209; GARS_A; 1. DR SMART; SM01210; GARS_C; 1. DR SUPFAM; SSF53328; Formyltransferase; 1. DR SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1. DR SUPFAM; SSF52440; PreATP-grasp domain; 1. DR SUPFAM; SSF56042; PurM C-terminal domain-like; 1. DR SUPFAM; SSF55326; PurM N-terminal domain-like; 1. DR SUPFAM; SSF51246; Rudiment single hybrid motif; 1. DR PROSITE; PS50975; ATP_GRASP; 1. DR PROSITE; PS00184; GARS; 1. DR PROSITE; PS00373; GART; 1. PE 2: Evidence at transcript level; KW Acetylation; ATP-binding; Ligase; Magnesium; Manganese; Metal-binding; KW Multifunctional enzyme; Nucleotide-binding; Phosphoprotein; KW Purine biosynthesis; Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P22102" FT CHAIN 2..1010 FT /note="Trifunctional purine biosynthetic protein adenosine- FT 3" FT /id="PRO_0000250715" FT DOMAIN 111..318 FT /note="ATP-grasp" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT REGION 434..809 FT /note="AIRS domain" FT /evidence="ECO:0000250|UniProtKB:P21872" FT REGION 810..1010 FT /note="GART domain" FT /evidence="ECO:0000250|UniProtKB:P22102" FT ACT_SITE 915 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P08179" FT BINDING 190..193 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 197 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 220 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 229 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 288 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT BINDING 290 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT BINDING 818..820 FT /ligand="N(1)-(5-phospho-beta-D-ribosyl)glycinamide" FT /ligand_id="ChEBI:CHEBI:143788" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 871 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 896..899 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 913 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 947..951 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 977..980 FT /ligand="N(1)-(5-phospho-beta-D-ribosyl)glycinamide" FT /ligand_id="ChEBI:CHEBI:143788" FT /evidence="ECO:0000250|UniProtKB:P22102" FT SITE 951 FT /note="Raises pKa of active site His" FT /evidence="ECO:0000250|UniProtKB:P08179" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 350 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 440 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 682 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 802 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT VARIANT 771 FT /note="K -> E" FT /evidence="ECO:0000269|PubMed:15777723" SQ SEQUENCE 1010 AA; 107907 MW; 27DFCA438661A771 CRC64; MAARVLVIGN GGREHTLAWK LAQSTHVKQV LVTPGNAGTA CSEKISNTDI SISDHTALAQ FCKDEKIEFV VVGPEAPLAA GIVGNLNSVG VRCFGPTAQA AQLESSKRFA KEFMDRHGIS TARWRAFTKP KEACDFIMSA DFPALVVKAS GLAAGKGVIV AKSKEEACEA VREIMQGKAF GEAGETVVIE ELLEGEEVSC LCFTDGRTVA PMPPAQDHKR LLEGDEGPNT GGMGAYCPAP QVSKDLLLKI KNNILQRTVD GMQEEGMPYT GVLYAGIMLT KNGPKVLEFN CRFGDPECQV ILPLLKSDLY EVIQSILDGL LCTSLPVWLD NCAAVTVVMA SKGYPGDYTK GVEITGFPEA QALGLEVFQA GTALKDGKVV TNGGRVLTVT AIRENLISAL EEARKGLAAI KFEGAVYRKD IGFRAIAFLQ QPRGLTYKES GVDIAAGNML VQKIKPLAKA TSRPGCDVDL GGFAGLFDLK AAGFTDPLLA CGTDGVGTKL KIAQQCSKHD TIGQDLVAMC VNDILAQGAE PLFFLDYFSC GKLDLRTTEA VITGIAKACK KAGCALLGGE TAEMPDMYPP GEYDLAGFAV GAMERDQKLP QLERITEGDA VIGIASSGLH SNGFSLVRKI VAKSSLEYSS PAPGGCGDQT LGDLLLTPTK IYSRSLLPVL RSGRVKAVAH ITGGGLLENI PRVLPQKLGV NLDAQTWRVP RIFSWLQQEG HLSEEEMART FNCGIGAALV VSEDLVKQTL QDIEQHQEEA CVIGRVVACP KGSPRVKVEH LIETMQINGS VLENGTLRNH FSVQPKKARV AVLISGTGSN LQALIDSTRE PSSLAHIVIV ISNKAAVAGL DKAEKAGIPT RVINHKLYKN RAAFDTAIDE VLEEFSTDIV CLAGFMRILS GPFVRKWNGK MLNIHPSLLP SFKGSNAHEQ VLDAGVTVTG CTVHFVAEDV DAGQIILQEA VPVKRGDTVE TLSERVKLAE HKIFPSALQL VASGAVRLGE NGRICWVTED //